KalVista Pharmaceuticals OverviewKalVista Pharmaceuticals Net Income
Profitability analysis for KALV.
Quarterly Net Income
-$5.37M
As of Mar 2026
Annual Net Income (TTM)
-$123.06M
↑ 30.03% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...